OTC · Biotechnology

BerGenBio ASA (BRRGF) Stock

$97.09 +0.00% OTC: BRRGF Healthcare

BerGenBio ASA is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing therapies for challenging conditions. This includes cancers that are immune-evasive, drug-resistant, or metastatic, as well as various respiratory diseases.

Valuation

MetricValue
Price$97.09
Market Cap$9.49B
P/E Ratio-1.26
P/B Ratio0.91
P/S Ratio24.52
EPS (TTM)$-125.02
52-Week High$97.09
52-Week Low$0.03
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-147.40%
ROA-76.71%
ROCE-97.98%
Gross Margin-204.27%
Operating Margin-896.18%
Net Margin-978.31%
Debt/Equity0.02
Current Ratio3.23

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$0$0$1.0M$23.0M
Operating Profit$-314.0M$-306.0M$-192.0M$-151.0M$-142.0M
Net Profit$-309.0M$-299.0M$-190.0M$-139.0M$-155.0M
EPS$-40.36$-38.65$-19.95$-11.65$-125.02
Op Margin-40628.4%-78569.4%-54186.2%-17834.2%-615.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$450.0M$167.0M$174.0M$156.0M$205.0M
Total Liabilities$66.0M$78.0M$47.0M$33.0M$59.0M
Cash$436.0M$150.0M$156.0M$140.0M$178.0M
Borrowings$2.0M$0$0$1.0M$4.0M

Latest News

TowneBank Q2 Earnings, Revenue Rise MT Newswires · Jul 23, 2026 Renault says sales stalled in first half AFP · Jul 23, 2026 Should You Buy Amazon and Meta Platforms Stocks Before July 29? Motley Fool · Jul 23, 2026 argenx Q2 Profit, Total Operating Income Rise MT Newswires · Jul 23, 2026 STMicroelectronics Q2 Non-GAAP Earnings, Revenue Rise MT Newswires · Jul 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-303.0M$-288.0M$-225.0M$-153.0M$-126.0M
Investing Cash Flow$0$3.0M$3.0M$4.0M$0
Financing Cash Flow$-1.0M$0$-37.0M$-9.0M$-3.0M
Net Cash Flow$-285.0M$-286.0M$6.0M$-16.0M$53.0M
Free Cash Flow$-303.0M$-288.0M$-225.0M$-153.0M$-126.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.57
FCF Yield-32.29%
Quick Ratio3.23
Interest Coverage-52.68
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
DOGPDogecoin Cash, Inc. $0.01 +5.06% 0.12 $1.35M 0.00%
FTHWFField Trip Health & Wellness Ltd. $0.04 +0.00% -0.34 $3.71M 0.00%
GHSIGuardion Health Sciences, Inc. $3.25 +0.93% 27.08 $4.17M 0.00%
IPCIFIntellipharmaceutics International Inc. $0.15 — -1.72 $4.96M 0.00%
IVITFInvictus MD Strategies Corp. $0.00 — 0.00 $4.45M 0.00%

About BerGenBio ASA

BerGenBio ASA is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing therapies for challenging conditions. This includes cancers that are immune-evasive, drug-resistant, or metastatic, as well as various respiratory diseases. Its leading drug candidate, Bemcentinib, is an orally available, small molecule AXL inhibitor that has progressed to Phase II clinical development. This involves studies across several significant cancer indications and for COVID-19. Specifically, its Phase II trials are focused on treating non-small cell lung cancer, acute myeloid leukemia, myelodysplastic syndrome, and COVID-19. Another promising compound in its pipeline is tilvestamab, an anti-AXL antibody currently undergoing Phase Ib clinical evaluation. The company maintains a collaborative agreement with Merck & Co. concerning its clinical trial initiatives. Founded in 2007, BerGenBio ASA is headquartered in Bergen, Norway.

BerGenBio ASA is headquartered in NO.

BerGenBio ASA (BRRGF) stock trades at $97.09 with a market capitalization of $9.49B. The stock is valued at a price-to-earnings (P/E) ratio of -1.26, price-to-book of 0.91, price-to-sales of 24.52. Over the past 52 weeks the stock has ranged between $0.03 and $97.09, and currently trades at its 52-week high.

On profitability, BerGenBio ASA generates a return on equity (ROE) of -147.40%, return on capital employed of -97.98%, an operating margin of -896.18%, a net profit margin of -978.31%.

Official website: www.bergenbio.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides